A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
1 other identifier
interventional
1,350
26 countries
332
Brief Summary
The study will assess the efficacy and safety of 2 dose regimens of pegozafermin compared to placebo for the treatment of liver fibrosis stage F2 or F3 in adult participants with MASH.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Mar 2024
Longer than P75 for phase_3
332 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 13, 2024
CompletedStudy Start
First participant enrolled
March 13, 2024
CompletedFirst Posted
Study publicly available on registry
March 19, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2029
ExpectedStudy Completion
Last participant's last visit for all outcomes
February 1, 2029
May 5, 2026
May 1, 2026
4.9 years
March 13, 2024
May 4, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Number of Participants With at Least an Improvement of Fibrosis ≥1 Stage Without Worsening of Steatohepatitis at Week 52
Worsening of steatohepatitis is defined as increase in non-alcoholic fatty liver disease (NAFLD) Activity Score (NAS) for ballooning, inflammation, or steatosis
Week 52
Number of Participants With Resolution of Steatohepatitis Without Worsening of Fibrosis at Week 52
Resolution of steatohepatitis is defined as total absence of ballooning (score=0) and absent or mild inflammation (score 0 to 1). Worsening of fibrosis is defined as progression of fibrosis by ≥1 stage.
Week 52
Time to First Occurrence of Disease Progression
Final analysis of the time to first occurrence of disease progression will be measured by a composite of protocol-specified clinical events
Up to 5 years
Secondary Outcomes (2)
Percent Change from Baseline in Alanine Aminotransferase at Week 52
Baseline, Week 52
Absolute Change From Baseline in Enhanced Liver Fibrosis (ELF) Score at Week 52
Baseline, Week 52
Study Arms (3)
Pegozafermin Regimen 1
EXPERIMENTALPegozafermin Regimen 2
EXPERIMENTALPlacebo
PLACEBO COMPARATORMatched Placebo will be administered in Regimens 1 and 2.
Interventions
Subcutaneous injection
Eligibility Criteria
You may qualify if:
- Males or non-pregnant females aged between 18 and 80 years (inclusive) at time of signing the informed consent form (ICF)
- Biopsy-confirmed MASH with fibrosis stage F2 or F3
- Body mass index (BMI) at screening ≥25.0 kilograms (kg)/meters squared (m\^2) (≥23 kg/m\^2 for Asian participants).
You may not qualify if:
- Chronic liver diseases other than MASH
- Evidence of cirrhosis on screening liver biopsy
- Have type 1 diabetes or poorly controlled type 2 diabetes
- Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) ≥250 units per liter (U/L)
- Participants taking vitamin E (\>400 international units \[IU\]/day) or pioglitazone must be on stable dose for at least 6 months prior to Screening
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- 89bio, Inc.lead
Study Sites (342)
89bio Clinical Study Site
Birmingham, Alabama, 35209, United States
89bio Clinical Study Site
Chandler, Arizona, 85224, United States
89bio Clinical Study Site
Flagstaff, Arizona, 86001, United States
89bio Clinical Study Site
Glendale, Arizona, 85036, United States
89bio Clinical Study Site
Tucson, Arizona, 85712, United States
89bio Clinical Study Site
Conway, Arkansas, 72032, United States
89bio Clinical Study Site
Little Rock, Arkansas, 72211-3859, United States
89bio Clinical Study Site
North Little Rock, Arkansas, 72117, United States
89bio Clinical Study Site
Canoga Park, California, 91604, United States
89bio Clinical Study Site
Coronado, California, 92118, United States
89bio Clinical Study Site
Fountain Valley, California, 92708, United States
89bio Clinical Study Site
Fresno, California, 93720, United States
89bio Clinical Study Site
Gardena, California, 90247, United States
89bio Clinical Study Site
Huntington Park, California, 90255, United States
89bio Clinical Study Site
Inglewood, California, 90301, United States
89bio Clinical Study Site
La Jolla, California, 92037, United States
89bio Clinical Study Site
Lancaster, California, 93534, United States
89bio Clinical Study Site
Long Beach, California, 90815, United States
89bio Clinical Study Site
Los Angeles, California, 90048, United States
89bio Clinical Study Site
Montclair, California, 91763, United States
89bio Clinical Study Site
Orange, California, 92868, United States
89bio Clinical Study Site
Panorama City, California, 91402, United States
89bio Clinical Study Site
Pasadena, California, 91105, United States
89bio Clinical Study Site
Poway, California, 92064, United States
89bio Clinical Study Site
Rialto, California, 92377, United States
89bio Clinical Study Site
Santa Ana, California, 92704-5763, United States
89bio Clinical Study Site
Stanford, California, 94305, United States
89bio Clinical Study Site
Victorville, California, 92395, United States
89bio Clinical Study Site
Colorado Springs, Colorado, 80923, United States
89bio Clinical Study Site
Littleton, Colorado, 80120, United States
89bio Clinical Study Site
Brandon, Florida, 33511, United States
89bio Clinical Study Site
Clermont, Florida, 34711, United States
89bio Clinical Study Site
Fort Myers, Florida, 33912, United States
89bio Clinical Study Site
Hialeah Gardens, Florida, 33016, United States
89bio Clinical Study Site
Homestead, Florida, 33030, United States
89bio Clinical Study Site
Jacksonville, Florida, 32256, United States
89bio Clinical Study Site
Jupiter, Florida, 33458, United States
89bio Clinical Study Site
Lady Lake, Florida, 32159-6831, United States
89bio Clinical Study Site
Lady Lake, Florida, 32159-8986, United States
89bio Clinical Study Site
Lakewood Rch, Florida, 34211, United States
89bio Clinical Study Site
Lehigh Acres, Florida, 33936, United States
89bio Clinical Study Site
Maitland, Florida, 32751-7258, United States
89bio Clinical Study Site
Maitland, Florida, 32751-7497, United States
89bio Clinical Study Site
New Port Richey, Florida, 34653, United States
89bio Clinical Study Site
Ocala, Florida, 34471, United States
89bio Clinical Study Site
Ocoee, Florida, 34761, United States
89bio Clinical Study Site
Sarasota, Florida, 34240, United States
89bio Clinical Study Site
Winter Park, Florida, 32789, United States
89bio Clinical Study Site
Athens, Georgia, 30607, United States
89bio Clinical Study Site
Dalton, Georgia, 30720, United States
89bio Clinical Study Site
Chicago, Illinois, 60611, United States
89bio Clinical Study Site
Hammond, Indiana, 46324, United States
89bio Clinical Study Site
New Albany, Indiana, 47150, United States
89bio Clinical Study Site
South Bend, Indiana, 46635, United States
89bio Clinical Study Site
Iowa City, Iowa, 52242, United States
89bio Clinical Study Site
Topeka, Kansas, 66606, United States
89bio Clinical Study Site
Covington, Louisiana, 70433, United States
89bio Clinical Study Site
Houma, Louisiana, 70360, United States
89bio Clinical Study Site
Lake Charles, Louisiana, 70605, United States
89bio Clinical Study Site
Marrero, Louisiana, 70072, United States
89bio Clinical Study Site
New Orleans, Louisiana, 70115, United States
89bio Clinical Study Site
West Monroe, Louisiana, 71291, United States
89bio Clinical Study Site
Baltimore, Maryland, 21202, United States
89bio Clinical Study Site
Glen Burnie, Maryland, 21061, United States
89bio Clinical Study Site
Greenbelt, Maryland, 20770, United States
89bio Clinical Study Site
Burlington, Massachusetts, 01805, United States
89bio Clinical Study Site
Chesterfield, Michigan, 48047, United States
89bio Clinical Study Site
Wyoming, Michigan, 49519, United States
89bio Clinical Study Site
Ypsilanti, Michigan, 48197, United States
89bio Clinical Study Site
Rochester, Minnesota, 55905, United States
89bio Clinical Study Site
Flowood, Mississippi, 39232, United States
89bio Clinical Study Site
St Louis, Missouri, 63123, United States
89bio Clinical Study Site
Las Vegas, Nevada, 89106, United States
89bio Clinical Study Site
Florham Park, New Jersey, 07932, United States
89bio Clinical Study Site
Freehold, New Jersey, 07728, United States
89bio Clinical Study Site
Warren Township, New Jersey, 07059, United States
89bio Clinical Study Site
Albuquerque, New Mexico, 87109, United States
89bio Clinical Study Site
Carmel, New York, 10512, United States
89bio Clinical Study Site
New York, New York, 10021, United States
89bio Clinical Study Site
New York, New York, 10033, United States
89bio Clinical Study Site
Charlotte, North Carolina, 28207, United States
89bio Clinical Study Site
Durham, North Carolina, 27710, United States
89bio Clinical Study Site
Fayetteville, North Carolina, 28304, United States
89bio Clinical Study Site
Morehead City, North Carolina, 28557, United States
89bio Clinical Study Site
Raleigh, North Carolina, 27612, United States
89bio Clinical Study Site
Winston-Salem, North Carolina, 27103, United States
89bio Clinical Study Site
Akron, Ohio, 44320, United States
89bio Clinical Study Site
Cleveland, Ohio, 44106, United States
89bio Clinical Study Site
Dayton, Ohio, 45414, United States
89bio Clinical Study Site
Liberty Township, Ohio, 45044, United States
89bio Clinical Study Site
Lima, Ohio, 45801, United States
89bio Clinical Study Site
Springboro, Ohio, 45066, United States
89bio Clinical Study Site
Westlake, Ohio, 44145, United States
89bio Clinical Study Site
East Greenwich, Rhode Island, 02818, United States
89bio Clinical Study Site
Charleston, South Carolina, 29425, United States
89bio Clinical Study Site
Columbia, South Carolina, 29204, United States
89bio Clinical Study Site
Chattanooga, Tennessee, 37421, United States
89bio Clinical Study Site
Cordova, Tennessee, 38018, United States
89bio Clinical Study Site
Hermitage, Tennessee, 37076, United States
89bio Clinical Study Site
Nashville, Tennessee, 37211, United States
89bio Clinical Study Site
Amarillo, Texas, 79106, United States
89bio Clinical Study Site
Austin, Texas, 78745, United States
89bio Clinical Study Site
Austin, Texas, 78757-8051, United States
89bio Clinical Study Site
Austin, Texas, 78757, United States
89bio Clinical Study Site
Bellaire, Texas, 77401, United States
89bio Clinical Study Site
Brownsville, Texas, 78520, United States
89bio Clinical Study Site
Corpus Christi, Texas, 78404, United States
89bio Clinical Study Site
DeSoto, Texas, 75115, United States
89bio Clinical Study Site
Edinburg, Texas, 78539, United States
89bio Clinical Study Site
Farmers Branch, Texas, 75234, United States
89bio Clinical Study Site
Fort Sam Houston, Texas, 78234, United States
89bio Clinical Study Site
Fort Worth, Texas, 76104, United States
89bio Clinical Study Site
Garland, Texas, 75044, United States
89bio Clinical Study Site
Georgetown, Texas, 78626, United States
89bio Clinical Study Site
Georgetown, Texas, 78628, United States
89bio Clinical Study Site
Houston, Texas, 77030, United States
89bio Clinical Study Site
Houston, Texas, 77099, United States
89bio Clinical Study Site
Katy, Texas, 77494, United States
89bio Clinical Study Site
San Antonio, Texas, 78209, United States
89bio Clinical Study Site
San Antonio, Texas, 78215, United States
89bio Clinical Study Site
San Antonio, Texas, 78222, United States
89bio Clinical Study Site
San Antonio, Texas, 78229-4801, United States
89bio Clinical Study Site
San Antonio, Texas, 78229, United States
89bio Clinical Study Site
Stafford, Texas, 77477, United States
89bio Clinical Study Site
Tomball, Texas, 77584, United States
89bio Clinical Study Site
Waco, Texas, 76301, United States
89bio Clinical Study Site
Waco, Texas, 76710, United States
89bio Clinical Study Site
Ogden, Utah, 84405, United States
89bio Clinical Study Site
Richmond, Virginia, 23226-1925, United States
89bio Clinical Study Site
Richmond, Virginia, 23229, United States
89bio Clinical Study Site
Richmond, Virginia, 23236, United States
89bio Clinical Study Site
Richmond, Virginia, 23298, United States
89bio Clinical Study Site
Roanoke, Virginia, 24014, United States
89bio Clinical Study Site
Seattle, Washington, 98101, United States
89bio Clinical Study Site
Seattle, Washington, 98105, United States
89bio Clinical Study Site
Buenos Aires, 1061, Argentina
89bio Clinical Study Site
Buenos Aires, 1125, Argentina
89bio Clinical Study Site
Buenos Aires, 1181, Argentina
89bio Clinical Study Site
Buenos Aires, C1012AAR, Argentina
89bio Clinical Study Site
Buenos Aires, C1425, Argentina
89bio Clinical Study Site
Caba, C1430CKE, Argentina
89bio Clinical Study Site
Capital Federal, C1280AEB, Argentina
89bio Clinical Study Site
Pilar, 1629, Argentina
89bio Clinical Study Site
Brisbane, Queensland, 4120, Australia
89bio Clinical Study Site
Herston, Queensland, 4019, Australia
89bio Clinical Study Site
South Brisbane, Queensland, 4101, Australia
89bio Clinical Study Site
Adelaide, South Australia, 5000, Australia
89bio Clinical Study Site
Bedford Park, South Australia, 5042, Australia
89bio Clinical Study Site
Clayton, Victoria, 3168, Australia
89bio Clinical Study Site
Heidelberg, Victoria, 3084, Australia
89bio Clinical Study Site
Perth, Western Australia, 6000, Australia
89bio Clinical Study Site
Fitzroy, 3065, Australia
89bio Clinical Study Site
Murdoch, 6150, Australia
89bio Clinical Study Site
Graz, 8036, Austria
89bio Clinical Study Site
Innsbruck, 6020, Austria
89bio Clinical Study Site
Klagenfurt, 9020, Austria
89bio Clinical Study Site
Sankt Pölten, 3100, Austria
89bio Clinical Study Site
Wels, 4600, Austria
89bio Clinical Study Site
Brussels, 1020, Belgium
89bio Clinical Study Site
Brussels, 1070, Belgium
89bio Clinical Study Site
Edegem, 2650, Belgium
89bio Clinical Study Site
Genk, 3600, Belgium
89bio Clinical Study Site
Ghent, 9000, Belgium
89bio Clinical Study Site
Jette, 1090, Belgium
89bio Clinical Study Site
Gorna Oryahovitsa, 5100, Bulgaria
89bio Clinical Study Site
Sofia, 1202, Bulgaria
89bio Clinical Study Site
Sofia, 1407, Bulgaria
89bio Clinical Study Site
Sofia, 1431, Bulgaria
89bio Clinical Study Site
Stara Zagora, 6003, Bulgaria
89bio Clinical Study Site
Calgary, Alberta, T2N 4Z6, Canada
89bio Clinical Study Site
Vancouver, British Columbia, V5Z 1M9, Canada
89bio Clinical Study Site
Vancouver, British Columbia, V6Z2K5, Canada
89bio Clinical Study Site
Winnipeg, Manitoba, R3T 2N2, Canada
89bio Clinical Study Site
London, Ontario, N6A 5A5, Canada
89bio Clinical Study Site
Ottawa, Ontario, K1H8L6, Canada
89bio Clinical Study Site
Toronto, Ontario, M5G2C4, Canada
89bio Clinical Study Site
Toronto, Ontario, M6H 3M1, Canada
89bio Clinical Study Site
Vaughan, Ontario, L4L 4Y7, Canada
89bio Clinical Study Site
Brno, 625 00, Czechia
89bio Clinical Study Site
Ostrava, 708 52, Czechia
89bio Clinical Study Site
Pilsen, 30100, Czechia
89bio Clinical Study Site
Amiens, 80080, France
89bio Clinical Study Site
Angers, 49933, France
89bio Clinical Study Site
Bordeaux, 33604, France
89bio Clinical Study Site
Lille, 59000, France
89bio Clinical Study Site
Limoges, 87042, France
89bio Clinical Study Site
Lyon, 69004, France
89bio Clinical Study Site
Montpellier, 34090, France
89bio Clinical Study Site
Nantes, 44093, France
89bio Clinical Study Site
Nice, 06200, France
89bio Clinical Study Site
Paris, 75012, France
89bio Clinical Study Site
Paris, 75013, France
89bio Clinical Study Site
Paris, 75014, France
89bio Clinical Study Site
Pierre-Bénite, 69310, France
89bio Clinical Study Site
Strasbourg, 67000, France
89bio Clinical Study Site
Toulouse, 31076, France
89bio Clinical Study Site
Toulouse, France
89bio Clinical Study Site
Vandœuvre-lès-Nancy, 54500, France
89bio Clinical Study Site
Vénissieux, 69200, France
89bio Clinical Study Site
Villejuif, 94800, France
89bio Clinical Study Site
Batumi, 6000, Georgia
89bio Clinical Study Site
Batumi, 6010, Georgia
89bio Clinical Study Site
Tbilisi, 0159, Georgia
89bio_Clinical Study Site
Tbilisi, 0159, Georgia
89bio Clinical Study Site
Tbilisi, 0177, Georgia
89bio Clinical Study Site
Chemnitz, 09116, Germany
89bio Clinical Study Site
Frankfurt am Main, 60596, Germany
89bio Clinical Study Site
Freiburg im Breisgau, 79106, Germany
89bio Clinical Study Site
Hanover, 30625, Germany
89bio Clinical Study Site
Homburg, 66421, Germany
89bio Clinical Study Site
Münster, 48149, Germany
89bio Clinical Study Site
Hong Kong, 0000, Hong Kong
89bio Clinical Study Site
Shatin, 0000, Hong Kong
89bio Clinical Study Site
Guwahati, Assam, 701032, India
89bio Clinical Study Site
Kolkata, West Bengal, 700150, India
89bio Clinical Study Site
Bhubaneswar, 751024, India
89bio Clinical Study Site
Gujrāt, 360001, India
89bio Clinical Study Site
Nagpur, 440012, India
89bio Clinical Study Site
Wardha, 442004, India
89bio Clinical Study Site
Afula, 1834111, Israel
89bio Clinical Study Site
Beersheba, 8410500, Israel
89bio Clinical Study Site
Haifa, 3109601, Israel
89bio Clinical Study Site
Haifa, 3436212, Israel
89bio Clinical Study Site
Jerusalem, Israel
89bio Clinical Study Site
Nahariya, 2210001, Israel
89bio Clinical Study Site
Petah Tikva, 4941492, Israel
89bio Clinical Study Site
Ramat Gan, 52621, Israel
89bio Clinical Study Site
Tel Aviv, 6971014, Israel
89bio Clinical Study Site
Tel Aviv, Israel
89bio Clinical Study Site
Bergamo, 24127, Italy
89bio Clinical Study Site
Milan, 20089, Italy
89bio Clinical Study Site
Milan, 20152, Italy
89bio Clinical Study Site
Milan, 20162, Italy
89bio Clinical Study Site
Modena, 41126, Italy
89bio Clinical Study Site
Naples, 80131, Italy
89bio Clinical Study Site
Novara, 28100, Italy
89bio Clinical Study Site
Palermo, 90127, Italy
89bio Clinical Study Site
Roma, 00128, Italy
89bio Clinical Study Site
Rome, 00136, Italy
89bio Clinical Study Site
Rome, 169, Italy
89bio Clinical Study Site
Torino, 10126, Italy
89bio Clinical Study Site
Maebashi, Gunma, 371-0821, Japan
89bio Clinical Study Site
Sapporo, Hokkaido, 065-0012, Japan
89bio Clinical Study Site
Hizume, Iwate, 028-3695, Japan
89bio Clinical Study Site
Kawasaki, Kanagawa, 215-0026, Japan
89bio Clinical Study Site
Yokohama, Kanagawa, 236-004, Japan
89bio Clinical Study Site
Ehime, 791-0295, Japan
89bio Clinical Study Site
Ehime, 798-8510, Japan
89bio Clinical Study Site
Fukuoka, 814-0180, Japan
89bio Clinical Study Site
Gifu, 500-8323, Japan
89bio Clinical Study Site
Kumamoto, 862-0971, Japan
89bio Clinical Study Site
Nagano, 381-0006, Japan
89bio Clinical Study Site
Okayama, 700-8558, Japan
89bio Clinical Study Site
Osaka, 545-0051, Japan
89bio Clinical Study Site
Osaka, 564-0013, Japan
89bio Clinical Study Site
Saga, 849-0937, Japan
89bio Clinical Study Site
Sapporo, 062-0921, Japan
89bio Clinical Study Site
Chihuahua City, 31217, Mexico
89bio Clinical Study Site
Cuautitlán Izcalli, 54769, Mexico
89bio Clinical Study Site
Jalisco, 44130, Mexico
89bio Clinical Study Site
Mexico City, 03330, Mexico
89bio Clinical Study Site
Mexico City, 06700, Mexico
89bio Clinical Study Site
Morelos, 62270, Mexico
89bio Clinical Study Site
Nuevo León, 64310, Mexico
89bio Clinical Study Site
Yucatán, 97070, Mexico
89bio Clinical Study Site
Rotterdam, South Holland, 3015C, Netherlands
89bio Clinical Study Site
Amsterdam, 1081HV, Netherlands
89bio Clinical Study Site
Utrecht, 3584CX, Netherlands
89bio Clinical Study Site
Katowice, 40-752, Poland
89bio Clinical Study Site
Krakow, 31-501, Poland
89bio Clinical Study Site
Lodz, 90-302, Poland
89bio Clinical Study Site
Lodz, 91-363, Poland
89bio Clinical Study Site
Mysłowice, 41-400, Poland
89bio Clinical Study Site
Warsaw, 00-215, Poland
89bio Clinical Study Site
Warsaw, 02-172, Poland
89bio Clinical Study Site
Warsaw, 04-501, Poland
89bio Clinical Study Site
Wroclaw, 53-673, Poland
89bio Clinical Study Site
Manati, 00674, Puerto Rico
89bio Clinical Study Site
Mayagüez, 00680, Puerto Rico
89bio Clinical Study Site
San Juan, 00927, Puerto Rico
89bio Clinical Study Site
Singapore, 119228, Singapore
89bio Clinical Study Site
Singapore, 169856, Singapore
89bio Clinical Study Site
Singapore, 308433, Singapore
89bio Clinical Study Site
Singapore, 529889, Singapore
89bio Clinical Study Site
Cape Town, 7530, South Africa
89bio Clinical Study Site
Johannesburg, 2196, South Africa
89bio Clinical Study Site
Worcester, 6850, South Africa
89bio Clinical Study Site
Busan, 49241, South Korea
89bio Clinical Study Site
Daegu, 42415, South Korea
89bio Clinical Study Site
Gyeonggi-do, 16247, South Korea
89bio Clinical Study Site
Incheon, 22332, South Korea
89bio Clinical Study Site
Seoul, 02447, South Korea
89bio Clinical Study Site
Seoul, 03080, South Korea
89bio Clinical Study Site
Seoul, 06591, South Korea
89bio Clinical Study Site
Seoul, 07061, South Korea
89bio Clinical Study Site
Seoul, 07985, South Korea
89bio Clinical Study Site
Seoul, 08308, South Korea
89bio Clinical Study Site
Barcelona, 08003, Spain
89bio Clinical Study Site
Barcelona, 08035, Spain
89bio Clinical Study Site
Barcelona, 08036, Spain
89bio Clinical Study Site
Barcelona, 08041, Spain
89bio Clinical Study Site
Barcelona, 08916, Spain
89bio Clinical Study Site
Córdoba, 14004, Spain
89bio Clinical Study Site
Madrid, 28007, Spain
89bio Clinical Study Site
Majadahonda, 28222, Spain
89bio Clinical Study Site
Málaga, 29010, Spain
89bio Clinical Study Site
Pontevedra, 36071, Spain
89bio Clinical Study Site
Santander, 39008, Spain
89bio Clinical Study Site
Santiago de Compostela, 15706, Spain
89bio Clinical Study Site
Seville, 41013, Spain
89bio Clinical Study Site
Chiayi City, 60002, Taiwan
89bio Clinical Study Site
Kaohsiung City, 807, Taiwan
89bio Clinical Study Site
Taipei, 100225, Taiwan
89bio Clinical Study Site
Adana, 1370, Turkey (Türkiye)
89bio Clinical Study Site
Ankara, 06230, Turkey (Türkiye)
89bio Clinical Study Site
Ankara, 06800, Turkey (Türkiye)
89bio Clinical Study Site
Bursa, 16110, Turkey (Türkiye)
89bio Clinical Study Site
Center, 53020, Turkey (Türkiye)
89bio Clinical Study Site
Fatih, 34093, Turkey (Türkiye)
89bio Clinical Study Site
Gaziantep, 27410, Turkey (Türkiye)
89bio Clinical Study Site
Istanbul, 34010, Turkey (Türkiye)
89bio Clinical Study Site
Istanbul, 34899, Turkey (Türkiye)
89bio Clinical Study Site
Izmir, 35360, Turkey (Türkiye)
89bio Clinical Study Site
Sarıçam, 01790, Turkey (Türkiye)
89bio Clinical Study Site
Umraniye, 34764, Turkey (Türkiye)
89bio Clinical Study Site
High Wycombe, Buckinghamshire, HP11 2QW, United Kingdom
89bio Clinical Study Site
Bristol, BS6 6LT, United Kingdom
89bio Clinical Study Site
Glasgow, G514TY, United Kingdom
89bio Clinical Study Site
Hull, HU3 2JZ, United Kingdom
89bio Clinical Study Site
London, E13 8SL, United Kingdom
89bio Clinical Study Site
London, E1, United Kingdom
89bio Clinical Study Site
London, NW32QG, United Kingdom
89bio Clinical Study Site
London, SE5 9RS, United Kingdom
89bio Clinical Study Site
London, W2 1NY, United Kingdom
89bio Clinical Study Site
Oxford, OX3 9DU, United Kingdom
89bio Clinical Study Site
Portsmouth, PO6 3LY, United Kingdom
89bio Clinical Study Site
Preston, PR2 9QB, United Kingdom
89bio Clinical Study Site
Southampton, SO16 6YD, United Kingdom
89bio Clinical Study Site
Stockton, TS19, United Kingdom
89bio Clinical Study Site
Sunderland, SR4 7TP, United Kingdom
89bio Clinical Study Site
Swansea, SA6, United Kingdom
89bio Clinical Study Site
York, YO24 4LJ, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Millie Gottwald, PharmD
89bio, Inc.
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 13, 2024
First Posted
March 19, 2024
Study Start
March 13, 2024
Primary Completion (Estimated)
February 1, 2029
Study Completion (Estimated)
February 1, 2029
Last Updated
May 5, 2026
Record last verified: 2026-05